| Dr Colin E Ramirez, MD | |
|
55 Carlton St, University Health Center, Athens, GA 30602-1503 | |
| (706) 542-8654 | |
| (706) 583-0393 |
| Full Name | Dr Colin E Ramirez |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 55 Carlton St, Athens, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376648758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101043189 (Virginia) | Primary |
| 208D00000X | General Practice | 72423 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Colin E Ramirez, MD 55 Carlton St, University Health Center, Athens, GA 30602-1503 Ph: (706) 542-8654 | Dr Colin E Ramirez, MD 55 Carlton St, University Health Center, Athens, GA 30602-1503 Ph: (706) 542-8654 |
News Archive
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
Poverty increases the risk of death and disability from non-communicable diseases, such as cancer, heart disease, stroke and diabetes in low- and middle-income countries, a new systematic review shows. Researchers also found evidence that developing an NCD increases the risk of falling into poverty in these countries.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
Earlier detection and treatment for Alzheimer's Disease are now more practical for larger segments of the population through a more refined use of existing, well-validated neuropsychological tests.
› Verified 4 days ago
James Nicholas Frisk, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 125 Telfair Pl, Athens, GA 30606 Phone: 706-548-2454 | |
Victor Morales, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-389-3000 Fax: 706-389-3839 | |
Charles F Potter, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-769-0005 | |
Dr. Ashley Marie Bohn, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Oglethorpe Ave Ste 600ef, Athens, GA 30606 Phone: 706-613-5980 | |
Nancy C Hendrix, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 225 Hawthorne Park, Athens, GA 30606 Phone: 706-613-6136 Fax: 706-353-1604 | |
Dr. Eugene Brannon Morris Iii, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1086 1/2 Baxter St, Athens, GA 30606 Phone: 706-353-0606 Fax: 706-353-0798 | |
Rajiv K Setia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 225 Hawthorne Park, Athens, GA 30606 Phone: 706-613-6136 Fax: 706-543-0706 |